Literature DB >> 27140407

Adoptive transfer of aminobisphonate-expanded Vγ9Vδ2+ T cells does not control HIV replication in a humanized mouse model.

Bhawna Poonia1.   

Abstract

AIM: Vγ9Vδ2 γδ T cells have effector potential against several cancers and infectious agents. Whether these cells control HIV replication was tested in humanized mouse model.
METHODS: NOD SCID gamma mice engrafted with human peripheral blood mononuclear cells (PBMCs) and infected with HIVBAL were treated with zoledronate-expanded Vγ9Vδ2 T cells either alone or in combination with an anti-HIV envelope antibody b12.
RESULTS: Severe depletion of CD4+CCR5+ T cells was observed in PBMCs of all infected mice. HIV plasma p24 levels were comparable in all infected groups with no decrease in plasma viremia achieved by adoptive transfer of cells.
CONCLUSION: Autologous transfer of ex vivo expanded Vγ9Vδ2 T cells may not be a successful treatment choice for controlling HIV replication in vivo.

Entities:  

Keywords:  HIV; Vγ9Vδ2; gamma delta; humanized mouse

Mesh:

Substances:

Year:  2016        PMID: 27140407      PMCID: PMC5705801          DOI: 10.2217/imt-2015-0003

Source DB:  PubMed          Journal:  Immunotherapy        ISSN: 1750-743X            Impact factor:   4.196


  22 in total

1.  Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer.

Authors:  Francesco Dieli; David Vermijlen; Fabio Fulfaro; Nadia Caccamo; Serena Meraviglia; Giuseppe Cicero; Andrew Roberts; Simona Buccheri; Matilde D'Asaro; Nicola Gebbia; Alfredo Salerno; Matthias Eberl; Adrian C Hayday
Journal:  Cancer Res       Date:  2007-08-01       Impact factor: 12.701

2.  Stimulated γδ T cells increase the in vivo efficacy of trastuzumab in HER-2+ breast cancer.

Authors:  Aude-Hélène Capietto; Ludovic Martinet; Jean-Jacques Fournié
Journal:  J Immunol       Date:  2011-06-13       Impact factor: 5.422

3.  Indirubin 3'-monoxime, from a Chinese traditional herbal formula, suppresses viremia in humanized mice infected with multidrug-resistant HIV.

Authors:  Alonso Heredia; Senthilkumar Natesan; Nhut M Le; Sandra Medina-Moreno; Juan C Zapata; Marvin Reitz; Joseph Bryant; Robert R Redfield
Journal:  AIDS Res Hum Retroviruses       Date:  2014-02-07       Impact factor: 2.205

Review 4.  Gammadelta T cells and Mycobacterium tuberculosis.

Authors:  W H Boom
Journal:  Microbes Infect       Date:  1999-03       Impact factor: 2.700

5.  Gamma delta T lymphocyte responses to HIV.

Authors:  M Wallace; S R Bartz; W L Chang; D A Mackenzie; C D Pauza; M Malkovsky
Journal:  Clin Exp Immunol       Date:  1996-02       Impact factor: 4.330

6.  Control of Plasmodium falciparum erythrocytic cycle: γδ T cells target the red blood cell-invasive merozoites.

Authors:  Giulia Costa; Séverine Loizon; Marianne Guenot; Iulia Mocan; Franck Halary; Geneviève de Saint-Basile; Vincent Pitard; Julie Déchanet-Merville; Jean-François Moreau; Marita Troye-Blomberg; Odile Mercereau-Puijalon; Charlotte Behr
Journal:  Blood       Date:  2011-11-01       Impact factor: 22.113

7.  Impact of persistent HIV replication on CD4 negative Vγ2Vδ2 T cells.

Authors:  Sarah Boudová; Haishan Li; Mohammad M Sajadi; Robert R Redfield; C David Pauza
Journal:  J Infect Dis       Date:  2012-03-26       Impact factor: 5.226

Review 8.  Potential of human gammadelta T lymphocytes for immunotherapy of cancer.

Authors:  Dieter Kabelitz; Daniela Wesch; Elke Pitters; Margot Zöller
Journal:  Int J Cancer       Date:  2004-12-10       Impact factor: 7.396

9.  Natural viral suppressors of HIV-1 have a unique capacity to maintain gammadelta T cells.

Authors:  David J Riedel; Mohammad M Sajadi; Cheryl L Armstrong; Jean-Saville Cummings; Cristiana Cairo; Robert R Redfield; C David Pauza
Journal:  AIDS       Date:  2009-09-24       Impact factor: 4.177

10.  The aminobisphosphonate pamidronate controls influenza pathogenesis by expanding a gammadelta T cell population in humanized mice.

Authors:  Wenwei Tu; Jian Zheng; Yinping Liu; Sin Fun Sia; Ming Liu; Gang Qin; Iris H Y Ng; Zheng Xiang; Kwok-Tai Lam; J S Malik Peiris; Yu-Lung Lau
Journal:  J Exp Med       Date:  2011-06-27       Impact factor: 14.307

View more
  2 in total

Review 1.  γδ T-cell responses during HIV infection and antiretroviral therapy.

Authors:  Jennifer A Juno; Emily M Eriksson
Journal:  Clin Transl Immunology       Date:  2019-07-17

Review 2.  The Unknown Unknowns: Recovering Gamma-Delta T Cells for Control of Human Immunodeficiency Virus (HIV).

Authors:  Shivkumar Biradar; Michael T Lotze; Robbie B Mailliard
Journal:  Viruses       Date:  2020-12-17       Impact factor: 5.818

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.